DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,372 filers reported holding DANAHER CORPORATION in Q1 2019. The put-call ratio across all filers is 1.02 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $321,807 | +16.1% | 1,288 | +16.0% | 0.05% | +11.4% |
Q1 2024 | $277,189 | +8.0% | 1,110 | +0.1% | 0.04% | +4.8% |
Q4 2023 | $256,556 | -6.8% | 1,109 | 0.0% | 0.04% | -6.7% |
Q3 2023 | $275,143 | +3.4% | 1,109 | 0.0% | 0.04% | +4.7% |
Q2 2023 | $266,160 | -3.7% | 1,109 | +1.1% | 0.04% | -6.5% |
Q1 2023 | $276,488 | -5.0% | 1,097 | 0.0% | 0.05% | -4.2% |
Q4 2022 | $291,166 | +2.9% | 1,097 | 0.0% | 0.05% | -4.0% |
Q3 2022 | $283,000 | +1.8% | 1,097 | +0.2% | 0.05% | +4.2% |
Q2 2022 | $278,000 | -15.8% | 1,095 | -2.6% | 0.05% | -7.7% |
Q1 2022 | $330,000 | -10.8% | 1,124 | 0.0% | 0.05% | -10.3% |
Q4 2021 | $370,000 | +7.9% | 1,124 | -0.2% | 0.06% | +5.5% |
Q3 2021 | $343,000 | +21.2% | 1,126 | +6.7% | 0.06% | +17.0% |
Q2 2021 | $283,000 | +18.4% | 1,055 | -0.7% | 0.05% | +2.2% |
Q1 2021 | $239,000 | 0.0% | 1,062 | -1.5% | 0.05% | -8.0% |
Q4 2020 | $239,000 | +3.0% | 1,078 | 0.0% | 0.05% | -7.4% |
Q3 2020 | $232,000 | +22.8% | 1,078 | +0.7% | 0.05% | +38.5% |
Q2 2020 | $189,000 | +29.5% | 1,071 | +1.5% | 0.04% | +14.7% |
Q1 2020 | $146,000 | -10.4% | 1,055 | -0.9% | 0.03% | 0.0% |
Q4 2019 | $163,000 | +5.8% | 1,065 | 0.0% | 0.03% | 0.0% |
Q3 2019 | $154,000 | +1.3% | 1,065 | 0.0% | 0.03% | +3.0% |
Q2 2019 | $152,000 | +7.8% | 1,065 | 0.0% | 0.03% | +10.0% |
Q1 2019 | $141,000 | +20.5% | 1,065 | -6.3% | 0.03% | +15.4% |
Q4 2018 | $117,000 | +1.7% | 1,137 | +7.8% | 0.03% | +13.0% |
Q3 2018 | $115,000 | -33.1% | 1,055 | -39.5% | 0.02% | -36.1% |
Q2 2018 | $172,000 | +0.6% | 1,744 | 0.0% | 0.04% | 0.0% |
Q1 2018 | $171,000 | – | 1,744 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |